Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy | Zendy

Miwa Kawanaka | Zendy; Ken Nishino | Zendy; Jun Nakamura | Zendy; Takahito Oka | Zendy; Noriyo Urata | Zendy; Daisuke Goto | Zendy; Mitsuhiko Suehiro | Zendy; Hirofumi Kawamoto | Zendy; Masatoshi Kudo | Zendy; Gotaro Yamada | Zendy

Open Access

Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

Author(s) -

Miwa Kawanaka,

Ken Nishino,

Jun Nakamura,

Takahito Oka,

Noriyo Urata,

Daisuke Goto,

Mitsuhiko Suehiro,

Hirofumi Kawamoto,

Masatoshi Kudo,

Gotaro Yamada

Publication year - 2014

Publication title -

liver cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.916

H-Index - 34

eISSN - 2235-1795

pISSN - 1664-5553

DOI - 10.1159/000343857

Subject(s) - hepatocellular carcinoma , hbsag , medicine , hepatitis b virus , hepatitis b , gastroenterology , immunology , virology , virus

Serum levels of hepatitis B virus (HBV) DNA are an important predictor of the risk of hepatocellular carcinoma (HCC) in patients with chronic HBV infection. However, little is known about whether high levels of hepatitis B surface antigen (HBsAg) increase the risk for HCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research